or
forgot password
  • cancer clinical trials in peoria, IL

  • Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Proctor Hospital

    Trial Locations
    Proctor Hospital
    OSF Saint Francis Medical Center
    Illinois Oncology Research Association CCOP
    Illinois CancerCare-Peoria
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
    Methodist Medical Center of Illinois

    Trial Locations
    Methodist Medical Center of Illinois
    Oncology Hematology Associates of Central Illinois, PC - Peoria
    OSF St. Francis Medical Center
    Proctor Hospital
    Leukemia
    Galiximab in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
    Oncology Hematology Associates of Central Illinois, PC - Peoria

    Trial Locations
    Oncology Hematology Associates of Central Illinois, PC - Peoria
    OSF St. Francis Medical Center
    Proctor Hospital
    Lymphoma
    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Oncology Hematology Associates of Central Illinois, PC - Peoria

    Trial Locations
    Oncology Hematology Associates of Central Illinois, PC - Peoria
    OSF St. Francis Medical Center
    Proctor Hospital
    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
    Oncology Hematology Associates of Central Illinois, PC - Peoria

    Trial Locations
    Oncology Hematology Associates of Central Illinois, PC - Peoria
    OSF St. Francis Medical Center
    Proctor Hospital
    Breast Cancer
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    OSF Saint Francis Medical Center

    Trial Locations
    OSF Saint Francis Medical Center
    Illinois Oncology Research Association CCOP
    Illinois CancerCare-Peoria
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
    OSF Saint Francis Medical Center

    Trial Locations
    OSF Saint Francis Medical Center
    Illinois Oncology Research Association CCOP
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
    CCOP - Illinois Oncology Research Association

    Trial Locations
    CCOP - Illinois Oncology Research Association
    Methodist Medical Center of Illinois
    Oncology Hematology Associates of Central Illinois, PC - Peoria
    OSF St. Francis Medical Center
    Brain and Central Nervous System Tumors
    Bortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
    Illinois Oncology Research Association CCOP

    Trial Locations
    Illinois Oncology Research Association CCOP
    Illinois CancerCare-Peoria
    Recurrent Mantle Cell Lymphoma
    Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
    Proctor Hospital

    Trial Locations
    Proctor Hospital
    OSF Saint Francis Medical Center
    Illinois Oncology Research Association CCOP
    Illinois CancerCare-Peoria
    Neuroendocrine Carcinoma
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    OSF Saint Francis Medical Center

    Trial Locations
    OSF Saint Francis Medical Center
    Illinois Oncology Research Association CCOP
    Illinois CancerCare-Peoria
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    OSF Saint Francis Medical Center

    Trial Locations
    OSF Saint Francis Medical Center
    Illinois Oncology Research Association CCOP
    Illinois CancerCare-Peoria
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    OSF Saint Francis Medical Center

    Trial Locations
    OSF Saint Francis Medical Center
    Illinois Oncology Research Association CCOP
    Illinois CancerCare-Peoria
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    OSF Saint Francis Medical Center

    Trial Locations
    OSF Saint Francis Medical Center
    Illinois Oncology Research Association CCOP
    Illinois CancerCare-Peoria
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
    Oncology Hematology Associates of Central Illinois, PC - Peoria

    Trial Locations
    Oncology Hematology Associates of Central Illinois, PC - Peoria
    OSF St. Francis Medical Center
    Proctor Hospital
    Lung Cancer